Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Troussard

Showing results (341-350 of 365) with videos related to

Pageof 37
Sort By:
Journal of Adolescent and Young Adult Oncology|May 16, 2020
Cancer Among Adolescents and Young Adults Between 2000 and 2016 in France: Incidence and Improved SurvivalThomas Raze, Brigitte Lacour, Anne Cowppli-Bony, et al.
Journal of Adolescent and Young Adult Oncology|March 17, 2025
Trends in the Incidence of Cancer Among Adolescents and Young Adults Between 2000 and 2020: A Study Based on French Population-Based Registry DataEmmanuel Desandes, Jacqueline Clavel, Florence Molinié, et al.
Blood|July 1, 1996
Factors influencing outcome in de novo myelodysplastic syndromes treated by allogeneic bone marrow transplantation: a long-term study of 71 patients Société Française de Greffe de MoelleL Sutton, C Chastang, P Ribaud, et al.
European Journal of Cancer (Oxford, England : 1990)|November 7, 2006
Survival of cancer patients in France: a population-based study from The Association of the French Cancer Registries (FRANCIM)N Bossard, M Velten, L Remontet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 10, 2023
Bortezomib-Dexamethasone, Rituximab, and Cyclophosphamide as First-Line Treatment for Waldenström's Macroglobulinemia: A Prospectively Randomized Trial of the European Consortium for Waldenström's MacroglobulinemiaChristian Buske, Meletios A Dimopoulos, Alexander Grunenberg, et al.
Hemasphere|October 16, 2020
Diagnosis and Treatment of Chronic Lymphocytic Leukemia: Recommendations of the French CLL Study Group (FILO)Anne Quinquenel, Thérèse Aurran-Schleinitz, Aline Clavert, et al.
Revue D'Epidemiologie Et De Sante Publique|April 10, 2003
Cancer incidence and mortality in France over the period 1978-2000L Remontet, J Estève, A-M Bouvier, et al.
Blood Advances|November 29, 2021
Humoral response to mRNA anti-COVID-19 vaccines BNT162b2 and mRNA-1273 in patients with chronic lymphocytic leukemiaCristina Bagacean, Rémi Letestu, Chadi Al-Nawakil, et al.
European Journal of Cancer (Oxford, England : 1990)|March 8, 2025
Long-term survival for myeloid neoplasms and national health expenditure: A EUROCARE-6 retrospective, population-based studyClaudia Vener, Roberto Lillini, Roberta De Angelis, et al.
Leukemia & Lymphoma|July 4, 2015
Evaluating abbreviated induction with fludarabine, cyclophosphamide, and dose-dense rituximab in elderly patients with chronic lymphocytic leukemiaCaroline Dartigeas, Eric Van Den Neste, Christian Berthou, et al.
Pageof 37

Showing results (341-350 of 365) with videos related to

Sort By:
Pageof 37
Journal of Adolescent and Young Adult Oncology|May 16, 2020
Cancer Among Adolescents and Young Adults Between 2000 and 2016 in France: Incidence and Improved SurvivalThomas Raze, Brigitte Lacour, Anne Cowppli-Bony, et al.
Journal of Adolescent and Young Adult Oncology|March 17, 2025
Trends in the Incidence of Cancer Among Adolescents and Young Adults Between 2000 and 2020: A Study Based on French Population-Based Registry DataEmmanuel Desandes, Jacqueline Clavel, Florence Molinié, et al.
Blood|July 1, 1996
Factors influencing outcome in de novo myelodysplastic syndromes treated by allogeneic bone marrow transplantation: a long-term study of 71 patients Société Française de Greffe de MoelleL Sutton, C Chastang, P Ribaud, et al.
European Journal of Cancer (Oxford, England : 1990)|November 7, 2006
Survival of cancer patients in France: a population-based study from The Association of the French Cancer Registries (FRANCIM)N Bossard, M Velten, L Remontet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 10, 2023
Bortezomib-Dexamethasone, Rituximab, and Cyclophosphamide as First-Line Treatment for Waldenström's Macroglobulinemia: A Prospectively Randomized Trial of the European Consortium for Waldenström's MacroglobulinemiaChristian Buske, Meletios A Dimopoulos, Alexander Grunenberg, et al.
Hemasphere|October 16, 2020
Diagnosis and Treatment of Chronic Lymphocytic Leukemia: Recommendations of the French CLL Study Group (FILO)Anne Quinquenel, Thérèse Aurran-Schleinitz, Aline Clavert, et al.
Revue D'Epidemiologie Et De Sante Publique|April 10, 2003
Cancer incidence and mortality in France over the period 1978-2000L Remontet, J Estève, A-M Bouvier, et al.
Blood Advances|November 29, 2021
Humoral response to mRNA anti-COVID-19 vaccines BNT162b2 and mRNA-1273 in patients with chronic lymphocytic leukemiaCristina Bagacean, Rémi Letestu, Chadi Al-Nawakil, et al.
European Journal of Cancer (Oxford, England : 1990)|March 8, 2025
Long-term survival for myeloid neoplasms and national health expenditure: A EUROCARE-6 retrospective, population-based studyClaudia Vener, Roberto Lillini, Roberta De Angelis, et al.
Leukemia & Lymphoma|July 4, 2015
Evaluating abbreviated induction with fludarabine, cyclophosphamide, and dose-dense rituximab in elderly patients with chronic lymphocytic leukemiaCaroline Dartigeas, Eric Van Den Neste, Christian Berthou, et al.
Pageof 37